Levetiracetam Noridem

Levetiracetam, the active ingredient in Levetiracetam Noridem, is an antiepileptic presented as an intravenous solution for injection use. It is employed to control seizure activity in patients with various types of epilepsy. The formulation is manufactured under EU standards and is supplied as a prescription‑only product.

GNH USA supplies Levetiracetam Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company provides reliable sourcing, regulatory documentation, and logistics support to healthcare institutions across global markets.

Levetiracetam is used in the management of epileptic disorders, targeting neuronal hyperexcitability.

Partial‑onset seizures: reduces frequency and severity of focal seizures. Myoclonic seizures: diminishes occurrence of sudden, brief muscle jerks. Generalized tonic‑clonic seizures: helps prevent loss of consciousness and convulsive episodes.

Levetiracetam may be associated with a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired or weak. - Somnolence: increased sleepiness during the day. - Headache: mild to moderate cranial pain. - Irritability: mood changes or agitation. - Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: rare skin blistering disorder. - Blood dyscrasias: abnormal blood counts. - Suicidal thoughts: emergence of depressive or suicidal ideation. - Severe depression: marked mood disturbances. - Rash with systemic symptoms: indicative of hypersensitivity.

When prescribing levetiracetam, clinicians should consider several precautionary measures to ensure safe use.

Renal impairment: dosage adjustment may be required based on renal function. Hepatic impairment: monitor liver enzymes and clinical response. Concomitant CNS depressants: increased sedation may occur. Pregnancy: risk category unknown; discuss potential benefits and risks with the patient. Driving and operating machinery: caution advised due to possible dizziness or drowsiness. Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Co‑administration with other antiepileptic drugs that markedly increase sedation (e.g., phenobarbital, benzodiazepines). - Use with strong enzyme‑inducing agents that may reduce levetiracetam plasma levels.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance central nervous system depression. - Fluoroquinolone antibiotics: potential to lower seizure threshold. - Immunosuppressants: monitor for altered immune response.